NasdaqGM - Nasdaq Real Time Price USD

Tango Therapeutics, Inc. (TNGX)

7.45 +0.12 (+1.71%)
As of 3:23 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
36,527.00
36,527.00
24,860.00
37,042.00
7,656.00
Operating Expense
150,700.00
150,700.00
135,931.00
95,232.00
59,856.00
Operating Income
-114,173.00
-114,173.00
-111,071.00
-58,190.00
-52,200.00
Net Non Operating Interest Income Expense
6,619.00
6,619.00
1,456.00
495.00
108.00
Other Income Expense
5,944.00
5,944.00
1,493.00
-248.00
120.00
Pretax Income
-101,610.00
-101,610.00
-108,122.00
-57,943.00
-51,972.00
Tax Provision
134.00
134.00
54.00
292.00
--
Net Income Common Stockholders
-101,744.00
-101,744.00
-108,176.00
-58,235.00
-51,972.00
Diluted NI Available to Com Stockholders
-101,744.00
-101,744.00
-108,176.00
-58,235.00
-51,972.00
Basic EPS
-1.08
--
-1.23
-0.94
-0.59
Diluted EPS
-1.08
--
-1.23
-0.94
-0.59
Basic Average Shares
94,572.45
--
87,820.04
62,108.03
87,474.26
Diluted Average Shares
94,572.45
--
87,820.04
62,108.03
87,474.26
Total Operating Income as Reported
-114,173.00
-114,173.00
-111,071.00
-58,190.00
-52,200.00
Total Expenses
150,700.00
150,700.00
135,931.00
95,232.00
59,856.00
Net Income from Continuing & Discontinued Operation
-101,744.00
-101,744.00
-108,176.00
-58,235.00
-51,972.00
Normalized Income
-101,744.00
-101,744.00
-108,176.00
-58,235.00
-51,972.00
Interest Income
6,619.00
6,619.00
1,456.00
495.00
108.00
Net Interest Income
6,619.00
6,619.00
1,456.00
495.00
108.00
EBIT
-114,173.00
-114,173.00
-111,071.00
-58,190.00
-52,200.00
EBITDA
-111,758.00
-111,758.00
-109,463.00
-57,293.00
-51,482.00
Reconciled Depreciation
2,415.00
2,415.00
1,608.00
897.00
718.00
Net Income from Continuing Operation Net Minority Interest
-101,744.00
-101,744.00
-108,176.00
-58,235.00
-51,972.00
Normalized EBITDA
-111,758.00
-111,758.00
-109,463.00
-57,293.00
-51,482.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
--
12/31/2020 - 9/3/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AURA Aura Biosciences, Inc.
7.23
+2.12%
 
TRDA Entrada Therapeutics, Inc.
12.68
+2.59%
 
RVMD Revolution Medicines, Inc.
35.92
+1.67%
 
KYMR Kymera Therapeutics, Inc.
33.67
+0.96%
 
RLAY Relay Therapeutics, Inc.
6.49
+5.44%
 
TYRA Tyra Biosciences, Inc.
15.69
+3.84%
 
RPTX Repare Therapeutics Inc.
3.1400
-0.32%
 
IDYA IDEAYA Biosciences, Inc.
39.73
+2.87%
 
AVBP ArriVent BioPharma, Inc.
15.53
-0.06%
 
CMPX Compass Therapeutics, Inc.
1.4300
-3.38%